<DOC>
	<DOCNO>NCT01187927</DOCNO>
	<brief_summary>This post-marketing study design ass safety efficacy Cervarix® vaccine Japanese female subject condition actual use .</brief_summary>
	<brief_title>Drug Use Investigation Cervarix®</brief_title>
	<detailed_description />
	<criteria>Subject must female Subject must age 10 Subject obvious fever Subject obvious severe acute disease Subject hypersensitivity component Cervarix® Other , subject inappropriate condition vaccination</criteria>
	<gender>Female</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>